Skip to main content

Deutsche Börse Acquires GMEX Group Stake

london-new-skyline
GMEX Group is based in London.

GMEX Group launched in August, planning to operate four markets for products that are moving from an over-the-counter (OTC) to exchange-traded status, including emerging contracts such as interest-rate swap futures. Deutsche Börse's stake was purchased for a figure in the "single-digit millions", according to GMEX.

"This investment in GMEX Group highlights our focus on using innovation to support the integrity and safety of the financial markets," says Andreas Preuss, deputy CEO at Deutsche Börse Group and CEO at Eurex. "The innovative business model provided by GMEX Group is the type of initiative the end users of the market want to see supported, to achieve this objective. Further, this extends our positioning in new products, including unique interest-rate swap futures contracts and the development of new market exchange segments, for a broad range of market participants in existing and emerging markets."

Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact info@waterstechnology.com or view our subscription options here: https://subscriptions.waterstechnology.com/subscribe

You are currently unable to copy this content. Please contact info@waterstechnology.com to find out more.

Expero sharpens focus on financial clients

After 20 years of delivering software, AI tools and digital UXs across industries, Expero is leaving its jack-of-all-trades strategy, aiming to become a master of one.

How fintechs can weather the funding winter

Investments into UK fintechs are slipping. Azimkhon Askarov, co-CEO and partner at Concryt, outlines strategies to help them through tough macroeconomic conditions in this guest column.

Most read articles loading...

You need to sign in to use this feature. If you don’t have a WatersTechnology account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here